TipRanks
Advertisement
Advertisement

HK:2197 Stock Latest News

Clover Posts Strong Phase 2 Data for Combination Respiratory Vaccines in Older Adults
Company AnnouncementsClover Posts Strong Phase 2 Data for Combination Respiratory Vaccines in Older Adults
15d ago
2197
Clover Biopharmaceuticals Swings to Profit on GAVI Gain as Cash Levels Tighten
PremiumCompany Announcements
Clover Biopharmaceuticals Swings to Profit on GAVI Gain as Cash Levels Tighten
27d ago
2197
Clover Biopharmaceuticals Sets Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany Announcements
Clover Biopharmaceuticals Sets Board Meeting to Approve Interim Results and Consider Dividend
1M ago
2197
Clover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement Gain
PremiumCompany Announcements
Clover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement Gain
2M ago
2197
Clover Biopharmaceuticals Wins Shareholder Backing for All AGM Resolutions
PremiumCompany Announcements
Clover Biopharmaceuticals Wins Shareholder Backing for All AGM Resolutions
3M ago
2197
Clover Biopharmaceuticals Tightens Insider Trading Compliance After Governance Review
PremiumCompany AnnouncementsClover Biopharmaceuticals Tightens Insider Trading Compliance After Governance Review
4M ago
2197
Clover Biopharmaceuticals Sets 2026 AGM to Renew Board Mandates and Share Issuance Authority
Premium
Company Announcements
Clover Biopharmaceuticals Sets 2026 AGM to Renew Board Mandates and Share Issuance Authority
4M ago
2197
Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
Premium
Company Announcements
Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
6M ago
2197
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
PremiumCompany Announcements
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
6M ago
2197
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
PremiumCompany Announcements
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
6M ago
2197
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
PremiumCompany Announcements
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
6M ago
2197
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
PremiumCompany Announcements
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
6M ago
2197
Clover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
PremiumCompany AnnouncementsClover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
6M ago
2197
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
6M ago
2197
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
Premium
Company Announcements
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
8M ago
2197
Clover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
PremiumCompany Announcements
Clover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
11M ago
2197
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
PremiumCompany Announcements
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
1y ago
2197
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
PremiumCompany Announcements
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
1y ago
2197
Clover Biopharmaceuticals Announces Board and Committee Changes
PremiumCompany Announcements
Clover Biopharmaceuticals Announces Board and Committee Changes
1y ago
2197
Clover Biopharmaceuticals Strengthens Governance with New Nomination Committee
PremiumCompany AnnouncementsClover Biopharmaceuticals Strengthens Governance with New Nomination Committee
1y ago
2197
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
Premium
Company Announcements
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
1y ago
2197
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
Premium
Company Announcements
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
1y ago
2197

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >